Development of porous HAp and β-TCP scaffolds by starch consolidation with foaming method and drug-chitosan bilayered scaffold based drug delivery system

Journal of Materials Science: Materials in Medicine

Volumn 21, Issue 11, 2010, Pages 2955-2969

  Kundu, B ^a   Lemos, A ^b   Soundrapandian, C ^a   Sen, P S ^a   Datta, S ^a   Ferreira, J M F ^b   Basu, D ^a  

^a CSIR CENTRAL GLASS AND CERAMIC RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL ACTIVITY; BIOACTIVE CERAMIC; BONE RESORPTION; CARRIER MATERIAL; CEFTRIAXONE; DEAD SPACE; DRUG DELIVERY SYSTEM; DRUG RELEASE; FTIR; HIGH CONCENTRATION; HIGH POROSITY; IN-VITRO; INTERCONNECTIVITY; LACTAMASES; LOCAL DRUG DELIVERY; POROUS SCAFFOLD; SCAFFOLD FABRICATION; SEM STUDY; STARCH CONSOLIDATION; TRI-CALCIUM PHOSPHATES; XRD;

BACTERICIDES; CALCIUM PHOSPHATE; CHITIN; CHITOSAN; DRUG DELIVERY; HYDROXYAPATITE; PARTICLE SIZE ANALYSIS; STARCH;

SCAFFOLDS;

CALCIUM PHOSPHATE; CHITOSAN; HYDROXYAPATITE; STARCH;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; FOAMING; INFRARED SPECTROSCOPY; OSTEOMYELITIS; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

CALCIUM PHOSPHATES; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DURAPATITE; POLYMERS; POROSITY; POWDERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STARCH; TISSUE SCAFFOLDS; VISCOELASTIC SUBSTANCES; X-RAY DIFFRACTION;

EID: 78349304138     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-010-4127-0     Document Type: Article

References (59)

1. C Soundrapandian S Datta B Sa 2007 Drug-eluting implants for osteomyelitis Crit Rev Ther Drug Carrier Syst 24 6 493 545 1:CAS:528: DC%2BD1cXjt12ntb8%3D 18298388
2. C Soundrapandian B Sa S Datta 2009 Organic-inorganic composites for bone drug delivery AAPS PharmSciTech 10 4 1158 1171 1:CAS:528:DC%2BC3cXovVGqsbo%3D 10.1208/s12249-009-9308-0 19842042
3. L Chen H Wang J Wang M Chen L Shang 2007 Ofloxacin-delivery system of a polyanhydride and polylactide blend used in the treatment of bone infection J Biomed Mater Res B Appl Biomater 83 2 589 595 17410574
4. N Efstathopoulos E Giamarellos-Bourboulis K Kanellakopoulou I Lazarettos P Giannoudis K Frangia, et al. 2008 Treatment of experimental osteomyelitis by methicillin resistant staphylococcus aureus with bone cement system releasing grepafloxacin Injury 39 12 1384 1390 10.1016/j.injury.2008.04.006 18656187
5. P Liu-Snyder TJ Webster 2008 Developing a new generation of bone cements with nanotechnology Curr Nanosci 4 1 111 118 1:CAS:528:DC%2BD1cXks1Wiuro%3D 10.2174/157341308783591799 2008CNan....4..111L (Pubitemid 351513469)
6. K Anagnostakos P Hitzler D Pape D Kohn J Kelm 2008 Persistence of bacterial growth on antibiotic-loaded beads: Is it actually a problem? Acta Orthop 79 2 302 307 10.1080/17453670710015120 18484259 (Pubitemid 351878362)
7. SK Nandi B Kundu SK Ghosh DK De D Basu 2008 Efficacy of nano-hydroxyapatite prepared by an aqueous solution combustion technique in healing bone defects of goat J Vet Sci 9 2 183 191 10.4142/jvs.2008.9.2.183 18487940
8. SK Nandi SK Ghosh B Kundu DK De D Basu 2008 Evaluation of new porous β-tri-calcium phosphate ceramic as bone substitute in goat model Small Ruminant Res 75 2-3 144 153 10.1016/j.smallrumres.2007.09.006
9. SK Ghosh SK Nandi B Kundu S Datta DK De SK Roy, et al. 2008 In vivo response of porous hydroxyapatite and beta-tricalcium phosphate prepared by aqueous solution combustion method and comparison with bioglass scaffolds J Biomed Mater Res B Appl Biomater 86 1 217 227 18161811
10. SK Nandi B Kundu SK Ghosh TK Mandal S Datta DK De, et al. 2009 Cefuroxime-impregnated calcium phosphates as an implantable delivery system in experimental osteomyelitis Ceram Int 35 4 1367 1376 1:CAS:528: DC%2BD1MXislGgsL4%3D 10.1016/j.ceramint.2008.07.022
11. SK Nandi P Mukherjee S Roy B Kundu DK De D Basu 2009 Local antibiotic delivery systems for the treatment of osteomyelitis-a review Mater Sci Engg C 29 8 2478 2485 1:CAS:528:DC%2BD1MXht1Ggu7rM 10.1016/j.msec.2009.07.014
12. SK Nandi B Kundu P Mukherjee TK Mandal S Datta DK De, et al. 2009 In vitro and in vivo release of cefuroxime axetil from bioactive glass as an implantable delivery system in experimental osteomyelitis Ceram Int 35 8 3207 3216 1:CAS:528:DC%2BD1MXhtFOku7rO 10.1016/j.ceramint.2009.05.005
13. Klawitter JJ, Hulbert SF. Application of porous ceramics for the attachment of load bearing internal orthopaedic application. J Biomed Mater Res Symposium No 2. 1971;Part 1:161-229.
14. de Groot K, Klein CPAT, Wolke JGC, de Blieck-Hogervorst JMA. Chemistry of calcium phosphate bioceramics. In: Yamamuro T, Hench LL, Wilson J, editors. Handbook of bioactive ceramics. Vol. 2: Calcium phosphate and hydroxylapatite ceramics. Boca Raton: CRC Press; 1990. p. 3-16.
15. EW White JN Weber DM Roy EL Owen RT Chiroff RA White 1975 Replamineform porous biomaterials for hard tissue implant applications J Biomed Mater Res 9 4 23 27 1:CAS:528:DyaE2MXls1ynsLY%3D 10.1002/jbm.820090406 1176505
16. SF Hulbert SJ Morrison JJ Klawitter 1972 Tissue reaction to three ceramics of porous and non-porous structures J Biomed Mater Res 6 5 347 374 1:CAS:528:DyaE38XltlSmt7k%3D 10.1002/jbm.820060505 4116127
17. I Sopyan M Mel S Ramesh K K.A. 2007 Porous hydroxyapatite for artificial bone applications Sci Tech Adv Mater 8 116 123 1:CAS:528:DC%2BD2sXisVKmu7s%3D 10.1016/j.stam.2006.11.017 (Pubitemid 46335890)
18. O Lyckfeldt JMF Ferreira 1998 Processing of porous ceramics by 'starch consolidation' J Eur Ceram Soc 18 2 131 140 1:CAS:528:DyaK1cXnsVOnsg%3D%3D 10.1016/S0955-2219(97)00101-5
19. Rutenberg M. Starch and its modifications. Handbook of water-soluble gums and resins. New York: McGraw Hill; 1979.
20. SM Shrivastava S Saurabh D Rai VK Dwivedi M Chaudhary 2009 In vitro microbial efficacy of sulbactomax: A novel fixed dose combination of ceftriaxone sulbactam and ceftriaxone alone Curr Drug Ther 4 1 73 77 1:CAS:528: DC%2BD1MXlt1Ggurk%3D 10.2174/157488509787081840
21. F Zhao WL Grayson T Ma B Bunnell WW Lu 2006 Effects of hydroxyapatite in 3-d chitosan-gelatin polymer network on human mesenchymal stem cell construct development Biomaterials 27 9 1859 1867 1:CAS:528:DC%2BD2MXht12isLvN 10.1016/j.biomaterials.2005.09.031 16225916 (Pubitemid 41759480)
22. L Zhang Q Ao A Wang G Lu L Kong Y Gong, et al. 2006 A sandwich tubular scaffold derived from chitosan for blood vessel tissue engineering J Biomed Mater Res A 77 2 277 284 16400655
23. Q Ao A Wang W Cao L Zhang L Kong Q He, et al. 2006 Manufacture of multimicrotubule chitosan nerve conduits with novel molds and characterization in vitro J Biomed Mater Res A 77 1 11 18 16345091
24. L Kong Y Gao W Cao Y Gong N Zhao X Zhang 2005 Preparation and characterization of nano-hydroxyapatite/chitosan composite scaffolds J Biomed Mater Res A 75 2 275 282 16044404
25. Kundu B, Sarkar R, Banerjee G, Panda C, Basu D, inventors; Central Glass and Ceramic Research Institute IFGL Bioceramics Limited, assignee. An improved process for the synthesis of pure beta-tri-calcium phosphate (β-tcp) useful for biomedical application (applied). India 2009.
26. B Kundu MK Sinha MK Mitra D Basu 2004 Fabrication and characterization of porous hydroxyapatite ocular implant followed by an in vivo study in dogs Bull Mater Sci 27 2 133 140 1:CAS:528:DC%2BD2cXjtlOntrc%3D 10.1007/BF02708495
27. LM Rodriguez-Lorenzo M Vallet-Regi JM Ferreira 2001 Colloidal processing of hydroxyapatite Biomaterials 22 13 1847 1852 1:CAS:528:DC%2BD3MXksVygu7c%3D 10.1016/S0142-9612(00)00366-5 11396889 (Pubitemid 32564973)
28. AF Lemos JD Santos JMF Ferreira 2003 New method for the incorporation of soluble bioactive glasses to reinforce porous ha structures Key Engg Mater 254-256 1033 1036
29. ASTM Standard C773-88. Standard test method for compressive (crushing) strength of fired whiteware materials. West Conshohocken, PA: ASTM International; 2006. doi: 10.1520/C0773-88R06.
30. Klug HP, Alexander LE. X-ray diffraction procedures: For polycrystalline and amorphous materials. 2 ed. ed. Weinheim: Wiley-VCH; 1974.
31. Cullity BD, Stock SR. Elements of x-ray diffraction. 2 ed. ed. New Jersey: Prentice Hall; 2001.
32. E Landi A Tampieri G Celotti S Sprio 2000 Densification behaviour and mechanisms of synthetic hydroxyapatites J Eur Ceram Soc 20 14-15 2377 2387 1:CAS:528:DC%2BD3cXptVWkt74%3D 10.1016/S0955-2219(00)00154-0 (Pubitemid 32072559)
33. RZ LeGeros 1991 Calcium phosphates in oral biology and medicine Monogr Oral Sci 15 1 201 1:STN:280:DyaK3MzjtlKjtw%3D%3D 1870604
34. CC Silva AG Pinheiro MAR Miranda JC Goes ASB Sombra 2003 Structural properties of hydroxyapatite obtained by mechanosynthesis Solid State Sci 5 4 553 558 1:CAS:528:DC%2BD3sXjtFWiur8%3D 10.1016/S1293-2558(03)00035-9 2003SSSci...5..553S
35. NY Mostafa 2005 Characterization, thermal stability and sintering of hydroxyapatite powders prepared by different routes Mater Chem Phys 94 2-3 333 341 1:CAS:528:DC%2BD2MXhtVGgur%2FJ 10.1016/j.matchemphys.2005.05.011 (Pubitemid 41508794)
36. M Yoshimura H Suda K Okamoto K Ioku 1994 Hydrothermal synthesis of biocompatible whiskers J Mater Sci 29 13 3399 3402 1:CAS:528:DyaK2cXltFGktrw%3D 10.1007/BF00352039 1994JMatS..29.3399Y
37. DG Nelson JD Featherstone 1982 Preparation, analysis, and characterization of carbonated apatites Calcif Tissue Int 34 Suppl 2 S69 S81 6293677
38. TRN Kutty 1970 Assignments of some bands in the infrared spectrum of b-tricalcium phosphate Ind J Chem 8 7 655 657 1:CAS:528:DyaE3cXkvFejsLo%3D
39. S Jinawath D Polchai M Yoshimura 2002 Low-temperature, hydrothermal transformation of aragonite to hydroxyapatite Mater Sci Engg C 22 1 35 39 10.1016/S0928-4931(02)00110-8
40. Rahaman MN. Ceramic processing and sintering. 2 ed. ed. New York: Marcel Dekker; 2003.
41. AF Lemos JMF Ferreira 2004 Combining foaming and starch consolidation methods to develop macroporous ha implants Key Engg Mater 254-256 1041 1044 10.4028/www.scientific.net/KEM.254-256.1041
42. Minnear WP. Processing of foamed ceramics. Ceramic transactions, forming science and technology for ceramics. Westemille, Ohio: The American Ceramic Society; 1992.
43. Gibson LJ, Ashby MF. Cellular solids: Structure and properties. 2 ed. ed. Cambridge: Cambridge University Press; 1997.
44. JH Kuhne R Bartl B Frisch C Hammer V Jansson M Zimmer 1994 Bone formation in coralline hydroxyapatite. Effects of pore size studied in rabbits Acta Orthop Scand 65 3 246 252 1:STN:280:DyaK2czhslCqtw%3D%3D 10.3109/ 17453679408995448 8042473
45. PS Eggli W Muller RK Schenk 1988 Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. A comparative histomorphometric and histologic study of bony ingrowth and implant substitution Clin Orthop Relat Res 232 127 138 1:CAS:528:DyaL1cXkvFyku78%3D 2838207
46. R Holmes V Mooney R Bucholz A Tencer 1984 A coralline hydroxyapatite bone graft substitute. Preliminary report Clin Orthop Relat Res 188 252 262 1:CAS:528:DyaL2MXht1ehsg%3D%3D 6147218
47. M Zhang T Tan H Yuan C Rui 2003 Insecticidal and fungicidal activities of chitosan and oligo-chitosan J Bioactive Compat Polym 18 5 391 400 1:CAS:528:DC%2BD3sXpvVGjtb0%3D 10.1177/0883911503039019 (Pubitemid 37474609)
48. S Bodhak S Bose A Bandyopadhyay 2009 Role of surface charge and wettability on early stage mineralization and bone cell-materials interactions of polarized hydroxyapatite Acta Biomater 5 6 2178 2188 1:CAS:528: DC%2BD1MXosVahu7g%3D 10.1016/j.actbio.2009.02.023 19303377
49. EG Lima RL Mauck SH Han S Park KW Ng GA Ateshian, et al. 2004 Functional tissue engineering of chondral and osteochondral constructs Biorheology 41 3-4 577 590 15299288
50. D Schaefer I Martin P Shastri RF Padera R Langer LE Freed, et al. 2000 In vitro generation of osteochondral composites Biomaterials 21 24 2599 2606 1:CAS:528:DC%2BD3cXmvFylsL0%3D 10.1016/S0142-9612(00)00127-7 11071609
51. MJ Mahoney WM Saltzman 2001 Transplantation of brain cells assembled around a programmable synthetic microenvironment Nat Biotechnol 19 10 934 939 1:CAS:528:DC%2BD3MXntl2ntLc%3D 10.1038/nbt1001-934 11581658 (Pubitemid 32947571)
52. B Palazzo MC Sidoti N Roveri A Tampieri M Sandri L Bertolazzi, et al. 2005 Controlled drug delivery from porous hydroxyapatite grafts: An experimental and theoretical approach Mater Sci Engg C 25 2 207 213 10.1016/j.msec.2005.01. 011 (Pubitemid 40584243)
53. JP Rissing 1997 Antimicrobial therapy for chronic osteomyelitis in adults: Role of the quinolones Clin Infect Dis 25 6 1327 1333 1:CAS:528:DyaK2sXotV2murg%3D 10.1086/516150 9431371
54. K Bush 1988 Beta-lactamase inhibitors from laboratory to clinic Clin Microbiol Rev 1 1 109 123 1:STN:280:DyaL1M%2Fnslertw%3D%3D 1282862 3060240
55. A Lebugle A Rodrigues P Bonnevialle JJ Voigt P Canal F Rodriguez 2002 Study of implantable calcium phosphate systems for the slow release of methotrexate Biomaterials 23 16 3517 3522 1:CAS:528:DC%2BD38XktFKjtb4%3D 10.1016/S0142-9612(02)00082-0 12099297 (Pubitemid 34615660)
56. AE Burgos JC Belchior RD Sinisterra 2002 Controlled release of rhodium (ii) carboxylates and their association complexes with cyclodextrins from hydroxyapatite matrix Biomaterials 23 12 2519 2526 1:CAS:528: DC%2BD38XivVShsLk%3D 10.1016/S0142-9612(01)00386-6 12033599 (Pubitemid 34292443)
57. LeGeros RZ, Bautista C, LeGeros JP, Vijaraghavan TV, Retino M. Comparative properties of bioactive bone graft materials. Bioceramics. London: Pergamon Press; 1995.
58. M Stigter J Bezemer K de Groot P Layrolle 2004 Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy J Control Release 99 1 127 137 1:CAS:528:DC%2BD2cXnt1Kjt7s%3D 10.1016/j.jconrel.2004.06.011 15342186 (Pubitemid 39165739)
59. M Prabaharan 2008 Chitosan derivatives as promising materials for controlled drug delivery J Biomater Appl 23 1 5 36 1:CAS:528: DC%2BD1cXptFygtb0%3D 10.1177/0885328208091562 18593819